Get the SPI Wire

Autonomix Medical, Inc.

NASDAQ:AMIX
Annual Meeting

of Shareholders

MEETING DATE

10/29/2026
DEF 14A FILED
09/14/2026
PUBLISHED
09/14/2026 9:02 pm
TIME TO PUBLISH
09/16/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:AMIX · CUSIP 05330T205 · CLASS common stock · CIK 0001617867

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

3
FOR
1
AGAINST
0
WITHHOLD
4
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
To elect six Board nominees to the Board of Directors of the Company, each to serve until the 2027 annual meeting of stockholders of the Company or until such person's successor is qualified and elected.
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Board approved and recommended all current members for re-election.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
To ratify the appointment of Forvis Mazars, LLP as the Company's independent registered public accounting firm for the year ending March 31, 2027.
auditor
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Audit Committee selected Forvis Mazars, LLP and pre-approves all audit and non-audit services.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
To approve an amendment to the Company's amended and restated certificate of incorporation to grant our Board of Directors authority to effect a reverse stock split of the outstanding shares of the Company's common stock, at a reverse stock split ratio of between 1-for-2 to 1-for-25 (or any whole number in between), as determined by the Board in its sole discretion, prior to the one-year anniversary of this Annual Meeting.
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states the proposal could have an anti-takeover effect and future issuances would likely dilute voting power.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
To approve the amended and restated 2023 Equity Incentive Plan.
compensation
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

As of the Record Date, only 353 shares remained available for issuance under the 2023 Plan.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

98df40b6f93e6eaae500518747f8ee044b5304f4e629566286b6f72e6a6c1a7d

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates